MultiMedRx Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 5/10
MultiMedRx falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the plan
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
MultiMedRx gates access behind a $100 fully refundable consultation fee, with medication pricing shown after intake. It is LegitScript-certified and keeps physical offices in Newport Beach, CA and Reno, NV. The site leads with brand-name GLP-1s, Ozempic, Wegovy and Zepbound, rather than the compounded-only model most peers use, and adds metformin, testosterone and HRT to a broader cardiometabolic menu.
Is MultiMedRx legit?
Yes. MultiMedRx is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 5.0/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a MultiMedRx promo or coupon code?
We know of no promo or coupon code for MultiMedRx. Coupon sites advertising "MultiMedRx discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how MultiMedRx compares on our rankings of the best semaglutide providers.
Vetted alternatives to MultiMedRx
Enhance MD
Best for: knowing which pharmacy fills the vial: it names Tru Meds Rx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
MultiMedRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Wegovy, Ozempic, Zepbound
- FDA status
- No FDA warning letters found
How MultiMedRx scores
Six columns, each one computed from something MultiMedRx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.0/10The listed figure is not a comparable monthly price for a named GLP-1 (it may be a membership fee, an insured copay, a per-vial rate or a starting-dose price), so Value is capped rather than scored against other sellers.
Effectiveness25%
9.0/10Dispenses semaglutide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
2.5/10No price appears until the medical intake is finished. A live video visit is required, which is slower but the more careful intake.
Trust & Safety15%
4.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on MultiMedRx
Last checked August 2026- Checked the listed price across 1 dose or plan tier
- Checked FDA warning letters for MultiMedRx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with MultiMedRx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1MultiMedRx shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2The intake requires a live video visit with a clinician before a first prescription, which takes longer than a written form and is the more careful route.
- 3Ask MultiMedRx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Before you commit, get the ongoing monthly price of the medication itself, not a first-month rate, a membership fee or a per-vial price.
- Confirm that MultiMedRx serves your state before you start.
Contacting MultiMedRx
- Phone
- 800-787-9659
Cancelling MultiMedRx
Taken from the terms MultiMedRx publishes. Terms change, so check the current policy before you subscribe.
- Refund policy
- Consultation fee fully refundable
GLP-1 medications MultiMedRx offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off MultiMedRx's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- We found no FDA warning letters issued to MultiMedRx
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Against it
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
What MultiMedRx charges
There is no standard monthly price to quote for MultiMedRx, so you cannot compare it with other sellers until you have been through an intake and received a quote. When you get one, ask for the ongoing monthly figure and what it includes, not the first-month rate and not a program total divided by its length.
What MultiMedRx dispenses
MultiMedRx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are FDA-approved brand-name products rather than compounded preparations, which is the more expensive route and the one where what is in the pen has been reviewed.
Safety and disclosure
Before you start an intake, ask MultiMedRx which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. We found no FDA warning letters issued to MultiMedRx. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want to compare prices before spending time on an intake. There is no standard monthly price to compare.
- You need insurance to cover the cost. Check whether MultiMedRx bills your plan before you start.
Our read
Whether MultiMedRx is priced well is impossible to judge before an intake, because there is no standard price to compare. That does not rule it out, and plenty of legitimate sellers quote after intake, but it puts the comparison after you have spent the time, which is the wrong order for you as the buyer. Collective is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
MultiMedRx falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay MultiMedRx
Check today's price, then start the intake.
Compare MultiMedRx head to head
The sellers closest to MultiMedRx on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this MultiMedRx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See MultiMedRx's current pricing
Whether you qualify is a clinician's decision, made after your intake.